Nano-biomaterials for cardiovascular applications: Clinical perspective

Area of Science:

• Biomaterials Science
• Cardiovascular Medicine
• Nanotechnology

Background:

• Cardiovascular diseases (CVDs) cause approximately 25% of global deaths and are increasing worldwide.
• Despite advances in diagnostics and therapy, effective treatments remain a challenge.
• Biomaterials offer advantages over synthetic materials for therapeutic and regenerative purposes.

Purpose of the Study:

• To review scientific literature on (nano)biomaterials for cardiovascular applications.
• To identify promising materials for improving existing therapies and developing novel constructs.
• To focus on the clinical relevance and potential of these biomaterials.

Main Methods:

• Systematic literature review of scientific reports.
• Focus on (nano)biomaterials relevant to cardiovascular diseases.
• Analysis of therapeutic, regenerative, and drug delivery applications.

Main Results:

• Biomaterials show potential as drug carriers and protective nanoshells.
• Nanoformulations enhance biocompatibility of imaging agents.
• Numerous promising (nano)biomaterials are being investigated for cardiovascular applications.

Conclusions:

• Biomaterials, particularly in nanoformulations, present significant opportunities for cardiovascular disease treatment and regeneration.
• Further research into novel biomaterial constructs can lead to improved cardiovascular care.
• The clinical translation of these advanced materials is a key future direction.